Using prescription registries to define continuous drug use: how to fill gaps between prescriptions

Pharmacoepidemiology and Drug Safety
Lars Hougaard NielsenNiels Keiding

Abstract

Pharmacoepidemiological studies often use prescription registries to assess patients' drug episodes. The databases usually provide information on the date of the redemption of the prescription as well as on the dispensed amount, and this allows us to define episodes of drug use. However, when patients take less medication than prescribed, apparent gaps between prescriptions occur, and most studies handle this issue by allowing for small gaps when defining continuous drug use. This paper argues that it becomes crucial whether gaps are 'filled' prospectively or retrospectively. In the latter case the inferred exposure status depends on the patient's future dispensing behaviour and this can lead to severe bias in the findings of the study. In this paper we investigate this potential bias in a study of the risk of acute myocardial infarction (AMI) for women using hormone therapy (HT), and we show that the retrospective exposure definition introduces an artificially protective effect of HT.

References

Jun 1, 1987·International Journal of Epidemiology·I PerssonH O Adami
May 1, 1997·Journal of Clinical Epidemiology·H S LauA Porsius
Aug 16, 2001·Epidemiology·C OlesenUNKNOWN EuroMAP Group
Apr 4, 2003·JAMA : the Journal of the American Medical Association·David N JuurlinkDonald A Redelmeier
Apr 3, 2004·Acta Obstetricia Et Gynecologica Scandinavica·Ellen Leth LøkkegaardHenrik Toft Sørensen
Dec 21, 2004·British Journal of Clinical Pharmacology·David N JuurlinkAndreas Laupacis
Dec 28, 2005·The American Journal of Medicine·Lynfa F StroudChaim M Bell
Dec 27, 2006·The Pharmacogenomics Journal·H SchellemanB H Ch Stricker

❮ Previous
Next ❯

Citations

Sep 26, 2012·Social Psychiatry and Psychiatric Epidemiology·Jaana T SuokasJari Tiihonen
Apr 17, 2013·European Journal of Clinical Pharmacology·Helle Wallach-KildemoesTheis Lange
Nov 1, 2011·Cancer Causes & Control : CCC·Lina Steinrud MørchØjvind Lidegaard
Nov 16, 2014·BMC Research Notes·Antti TanskanenJari Tiihonen
Apr 21, 2012·American Journal of Epidemiology·Lina Steinrud MørchOjvind Lidegaard
Oct 1, 2015·International Journal of Cancer. Journal International Du Cancer·Lina S MørchØjvind Lidegaard
Aug 21, 2015·International Journal of Cancer. Journal International Du Cancer·Marta RománSolveig Hofvind
May 25, 2013·Pharmacoepidemiology and Drug Safety·Anton Pottegård, Jesper Hallas
Feb 3, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Pasi KorhonenJari Haukka
Apr 19, 2015·BMC Medical Informatics and Decision Making·Antti TanskanenJari Tiihonen
Jun 29, 2016·Fundamental & Clinical Pharmacology·Aurore PalmaroMaryse Lapeyre-Mestre
Nov 30, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Andreas D MeidWalter E Haefeli
Jan 20, 2018·International Journal of Cancer. Journal International Du Cancer·Ellen Christine Leth Løkkegaard, Lina Steinrud Mørch
Aug 14, 2019·Obstetrics and Gynecology·Tina Raine-BennettJoan C Lo
Feb 14, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Tongtong WangCarol E Koro
Dec 7, 2017·The New England Journal of Medicine·Lina S MørchØjvind Lidegaard
Jan 14, 2016·European Journal of Epidemiology·Lina Steinrud MørchSusanne Krüger Kjær
Dec 30, 2017·Pharmacoepidemiology and Drug Safety·Laura PazzagliShahram Bahmanyar
Mar 2, 2019·Thérapie·Agnès Sommet, Antoine Pariente
Jul 12, 2021·European Journal of Clinical Pharmacology·Marianne MeaidiMaurizio Sessa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.